Andrea Difabio
Chief Legal Officer · Xenon Pharmaceuticals Inc.
- 2026
- Mar 14, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrea Difabio files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ian Mortimer - $21.42M in XENE purchases and sales in the last 12 months
- Christopher John Kenney - $670K in XENE purchases and sales in the last 12 months
- Steven Gannon - $641K in XENE purchases and sales in the last 12 months
- Thomas Patrick Kelly - $560K in XENE purchases and sales in the last 12 months
- Gary Patou - $70K in XENE purchases and sales in the last 12 months
- Gillian Cannon - $63K in XENE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrea Difabio?
Andrea Difabio is a corporate insider, tracked as Chief Legal Officer of Xenon Pharmaceuticals Inc. (XENE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Andrea Difabio last file a Form 4?
The most recent primary Form 4 on record is dated 14 March 2026, one of 3 filings going back to 2026.
Has Andrea Difabio been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($231K) across all tracked filings.
